Europe’s medicines regulator confirmed that leukoencephalopathy is a rare but serious side effect of levamisole-containing medicines.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/eu-withdrawal-levamisole-recommended-due-cns-risks-2026a10004pl?src=rss
Author :
Publish date : 2026-02-13 15:47:00
Copyright for syndicated content belongs to the linked Source.
